1. Pharmacogenomics education in medical and pharmacy schools: conclusions of a global survey
- Author
-
Chiara Di Resta, Ivan Brandslund, Christodoulos S. Flordellis, Julia C. Stingl, Pieter Vermeersch, Ingolf Cascorbi, George Dedoussis, Adrián LLerena, Sofia Siest, Irena Prodan Žitnik, Uwe Fuhr, Janja Marc, Jeantine E. Lunshof, Mario Pazzagli, David Gurwitz, Nataša Karas Kuželički, Maurizio Simmaco, Personalized Therapy, Vangelis G. Manolopoulos, Marc Ansari, Ron H.N. van Schaik, Matthias Schwab, University of Ljubljana, Sackler Faculty of Medicine, Tel Aviv University [Tel Aviv], Kiel University, Interactions Gène-Environnement en Physiopathologie Cardio-Vasculaire (IGE-PCV), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Università degli Studi di Roma 'La Sapienza' = Sapienza University [Rome], Hôpital Universitaire de Genève, Faculté de médecine [Genève], Università degli Studi di Firenze = University of Florence [Firenze] (UNIFI), Universita Vita Salute San Raffaele = Vita-Salute San Raffaele University [Milan, Italie] (UniSR), IRCCS San Raffaele Scientific Institute [Milan, Italie], Dr. Margarete Fischer-Bosch Institute for Clinical Pharmacology [Stuttgart], University of Tübingen, University Hospitals Leuven [Leuven], University Medical Center Groningen [Groningen] (UMCG), Harvard Medical School [Boston] (HMS), Massachusetts Institute of Technology (MIT), Harokopio University of Athens, University of Patras [Patras], University of Cologne, Universitätsklinikum Bonn (UKB), Erasmus University Medical Center [Rotterdam] (Erasmus MC), Democritus University of Thrace (DUTH), Clinical Chemistry, Karas Kuželički, Nataša, Prodan Žitnik, Irena, Gurwitz, David, Llerena, Adrian, Cascorbi, Ingolf, Siest, Sofia, Simmaco, Maurizio, Ansari, Marc, Pazzagli, Mario, Di Resta, Chiara, Brandslund, Ivan, Schwab, Matthia, Vermeersch, Pieter, Lunshof, Jeantine E, Dedoussis, George, Flordellis, Christodoulos S, Fuhr, Uwe, Stingl, Julia C, van Schaik, Ron Hn, Manolopoulos, Vangelis G, and Marc, Janja
- Subjects
medicine ,[SDV]Life Sciences [q-bio] ,Pharmacy ,Global survey ,Recommendations ,030226 pharmacology & pharmacy ,PHYSICIANS ,0302 clinical medicine ,Surveys and Questionnaires ,Pharmacology & Pharmacy ,Schools, Medical ,ComputingMilieux_MISCELLANEOUS ,education ,0303 health sciences ,ddc:618 ,CHALLENGES ,Education, Medical ,4. Education ,Health professions ,3. Good health ,Molecular Medicine ,Medicine ,Curriculum ,Psychology ,Life Sciences & Biomedicine ,pharmacy ,pharmacogenomic ,global survey ,Education ,03 medical and health sciences ,FUTURE ,Genetics ,KNOWLEDGE ,ATTITUDES ,030304 developmental biology ,pharmacogenomics ,HEALTH-CARE PROFESSIONALS ,Pharmacology ,Medical education ,Science & Technology ,US ,business.industry ,Education, Pharmacy ,Pharmacogenetics ,Schools, Pharmacy ,Pharmacogenomics ,recommendations ,PERSONALIZED MEDICINE ,business - Abstract
Aim: The need for pharmacogenomic education is becoming more and more urgent. Our aim was to evaluate the progress in pharmacogenomics education since then, and to put forward further recommendations. Methods: A survey was sent to 248 schools of medicine, pharmacy, nursing and health professions around the world. Results: The majority of the study programs (87%) include pharmacogenomics education, which is generally taught as part of the pharmacology curriculum. On average, educators and teachers have selected appropriate and highly relevant pharmacogenomics biomarkers to include in their teaching programs. Conclusions: Based on the results, we can conclude that the state of pharmacogenomics education at the surveyed universities has improved substantially since 2005. ispartof: PHARMACOGENOMICS vol:20 issue:9 pages:643-657 ispartof: location:England status: published
- Published
- 2019
- Full Text
- View/download PDF